Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Week 48 endpoint analysis from the Company’s Phase 2 SOLSTICE trial for chronic hepatitis delta (CHD) demonstrated that participants ...

Discover a study showing how the Mediterranean diet reduces liver fat in MASLD while promoting environmentally sustainable ...

Francis Collins, the former NIH director, tells liver researcher that the partisanship that has pervaded science "is really a ...

Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, ...

An investigational triple agonist that targets fibroblast growth factor 21, glucagon and GLP-1 receptors cut triglyceride ...

It started with wine. Or more precisely, a conversation about it. "My colleagues and I were talking about how some people ...

GSK (GSK) will showcase latest advances in its liver pipeline, with 21 abstracts presented at the American Association for the Study of Liver ...

AI-based digital pathology analysis provides high-resolution quantification of hepatic fibrosis and objective measurement of fibrosis ...

Bowlus, M.D., FAASLD, Lena Valente Professor and chief of the division of gastroenterology and hepatology at the University of California Davis School of Medicine. "ALP is our primary measure of ...

An economic evaluation found that screening followed by intensive lifestyle intervention plus either semaglutide (Ozempic, ...

Despite updated guidelines, substantial variation remains in how expert gastroenterologists manage Barrett esophagus, ...